Wize Pharma Documents
Documents
0
Ticker
WIZP
ISIN
US97751M2070
Wize Pharma SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Wize Pharma Documents 2026
This page contains all official documents and SEC filings for Wize Pharma stock (WIZP, ISIN: US97751M2070). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Wize Pharma's regulatory filings.
Wize Pharma Stock analysis
Wize Pharma Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases.